When George Scangos became Biogen Idec Inc.’s chief executive officer in mid-2010, the share price was languishing in the $50 range and the company was reeling from a bruising battle with activist investor Carl Icahn.
Within months, Scangos, a Boston-area native and former Johns Hopkins University biology professor, was cutting the workforce, spinning off assets and getting out of some lines of business -- tasks no executive would relish.
Hey, check out all the research scientist jobs. Post your resume today!
